| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
15,581 |
14,452 |
$782K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
5,309 |
4,868 |
$199K |
| 94729 |
|
3,796 |
3,594 |
$120K |
| 94726 |
|
3,857 |
3,645 |
$118K |
| 94060 |
|
3,327 |
3,138 |
$99K |
| 95811 |
|
213 |
206 |
$85K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
470 |
449 |
$41K |
| 99205 |
Prolong outpt/office vis |
201 |
190 |
$21K |
| 99245 |
|
106 |
106 |
$19K |
| 95810 |
Polysomnography; sleep staging with 4 or more additional parameters |
44 |
42 |
$19K |
| 94010 |
|
708 |
684 |
$15K |
| 95813 |
|
41 |
38 |
$9K |
| 99244 |
Office or other outpatient consultation, moderate to high complexity |
60 |
59 |
$8K |
| 94664 |
|
281 |
252 |
$3K |
| 99215 |
Prolong outpt/office vis |
29 |
25 |
$2K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
14 |
12 |
$837.24 |
| 82962 |
|
463 |
411 |
$427.94 |
| J7611 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg |
777 |
696 |
$59.61 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
1,074 |
1,044 |
$26.70 |
| G8420 |
Bmi is documented within normal parameters and no follow-up plan is required |
423 |
347 |
$0.00 |
| G8418 |
Bmi is documented below normal parameters and a follow-up plan is documented |
73 |
50 |
$0.00 |
| G8417 |
Bmi is documented above normal parameters and a follow-up plan is documented |
1,379 |
1,196 |
$0.00 |